Mitochondrial abnormalities in Alzheimer's disease

Journal of Neuroscience

Volumn 21, Issue 9, 2001, Pages 3017-3023

  Hirai, Keisuke ^a,b   Aliev, Gjumrakch ^a   Nunomura, Akihiko ^a,c   Fujioka, Hisashi ^a   Russell, Robert L ^a   Atwood, Craig S ^a   Johnson, Anne B ^d   Kress, Yvonne ^d   Vinters, Harry V ^e   Tabaton, Massimo ^f   Shimohama, Shun ^g   Cash, Adam D ^a   Siedlak, Sandra L ^a   Harris, Peggy L R ^a   Jones, Paul K ^a   Petersen, Robert B ^a   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF GENOA   (Italy)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Free radicals; Metabolism; Mitochondria; Neurodegeneration; Oxidative stress

Indexed keywords

CYTOCHROME C OXIDASE; FREE RADICAL; MITOCHONDRIAL DNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN MITOCHONDRION; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN TISSUE; MITOCHONDRION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0035341254     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-09-03017.2001     Document Type: Article

References (35)

1. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease
2. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation
3. A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis
4. Lipopigment changes in Purkinje cells in Alzheimer's disease
5. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of crosslinked protein that inhibits the multicatalytic protease
6. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative
7. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease
8. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: Reaction of lipoic acid with 4-hydroxy-2-nonenal
9. Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease
10. Alzheimer's disease
11. Diagnosis of Alzheimer's disease
12. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways
13. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide
14. Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases
15. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
16. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
17. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures
18. Specific detection of deleted mitochondrial DNA by in situ hybridization using a chimera probe
19. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease
20. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
21. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components
22. Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton
23. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation
24. Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: An index of oxidative stress
25. Filament heterogeneity Within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease
26. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
27. Alzheimer disease
28. Oxidative damage in Alzheimer's
29. Widespread peroxynitrite-mediated damage in Alzheimer's disease
30. A morphometric study of the blood-brain barrier in Alzheimer's disease
31. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines
32. Cytochrome oxidase in Alzheimer's disease: Biochemical, histochemical, and immunohistochemical analyses of the visual and other systems
33. Activation of p38 pathway links tau phosphorylation, oxidative stress and cell cycle related events in Alzheimer disease
34. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease